[Influence of the dimension of crystalls on the pharmacological activity and absorption of a new anti-inflammatory composition: phthalazino-(2,3-b)-phthalazine-5,(14H), 12(7H)-dione].
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D006571:Heterocyclic Compounds / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D007408:Intestinal Absorption / Q000187:drug effects; D010316:Particle Size; D051381:Rats
D000893:Anti-Inflammatory Agents; D006571:Heterocyclic Compounds
Influenza della dimensione dei cristalli sull'attività farmacologica e sull'assorbimento di un nuovo composto antiinflammatorio: lo ftalazino-(2,3-b)-ftalazin-5,(14H), 12(7H)-dione.